Coverage

Clinical

Every Clinical story we’ve published, newest first — each one sourced to the primary record.

All coverage

40 stories

FDA

FDA Approves Fall 2026 COVID Shots, Keeps Narrow Use

Aug 30, 20265 min read

FDA

FDA Warns Alar Over Ads for Its Unapproved Ketamine Drug

Aug 30, 20264 min read

Clinical

FDA Approves First Drug for Polycythemia Vera

Aug 28, 20264 min read

Clinical

FDA Approves First Oral Drug for Dermatomyositis

Aug 27, 20265 min read

FDA

FDA Approves Rasonque, First RAS-Targeted Cancer Drug

Aug 26, 20265 min read

FDA

FDA Approves Ziihera Regimens for Gastric Cancer

Aug 25, 20265 min read

Clinical

EU Approves GSK’s Twice-Yearly Asthma Drug Exdensur

Aug 25, 20265 min read

FDA

FDA Extends Review of Capricor’s Duchenne Therapy

Aug 24, 20265 min read

Clinical

EU Clears Tecvayli Plus Daratumumab for Myeloma

Aug 24, 20265 min read

FDA

FDA Finalizes FAQ Guide for Cell, Gene Therapies

Aug 23, 20266 min read

Devices

MHRA Warns Against Infant Gas-Relief Catheters

Aug 23, 20265 min read

Clinical

FDA Approves First Gene Therapy for GSDIa

Aug 20, 20266 min read

Devices

FDA Authorizes First Robotic Blood-Draw Device

Aug 20, 20266 min read

FDA

FDA Eases Path for Cancer Companion Diagnostics

Aug 19, 20265 min read

Clinical

MHRA Clarifies UK Path for Microbiome Medicines

Aug 19, 20265 min read

FDA

FDA Clears LEROCHOL Autoinjector, Adds CV Risk Claim

Aug 18, 20265 min read

Devices

FDA Sets a September Panel on GRAIL’s Galleri Blood Test

Aug 17, 20266 min read

Devices

FDA Grants Breakthrough Status to Freenome Lung Test

Aug 16, 20265 min read

Clinical

MHRA Approves Vimseltinib for Giant Cell Tumours

Aug 15, 20264 min read

FDA

FDA Approves Bristol Myers’ First CELMoD for Myeloma

Aug 14, 20264 min read

Clinical

UK First in Europe to Approve Lilly’s Foundayo Pill

Aug 13, 20265 min read

FDA

FDA Warns Investigator Over Trial Drug Accountability

Aug 13, 20265 min read

FDA

FDA Approves Replimune’s Twice-Rejected Melanoma Drug

Aug 6, 20266 min read

FDA

FDA Approves Takeda’s Orzeyful for Narcolepsy Type 1

Aug 5, 20264 min read

Clinical

MHRA Plans a 14-Day First Review for Phase 1 Trials

Aug 4, 20265 min read

FDA

FDA Approves First mRNA Flu Vaccine, Moderna’s mFLUSIVA

Aug 5, 20266 min read

Devices

FDA Clears BlueWind’s Revi Extend Bladder Implant

Aug 5, 20265 min read

Clinical

MHRA’s ILAP Passports Go to Liver Cancer, Dementia Drugs

Aug 4, 20265 min read

FDA

FDA Debars Research Site Owners Who Faked Trial Data

Aug 3, 20265 min read

FDA

FDA Grants Breakthrough Status to Lilly’s KRAS Drug

Aug 3, 20264 min read

FDA

FDA Panel Votes 9-3 Against Capricor’s DMD Heart Drug

Aug 2, 20266 min read

Guidance

FDA Finalizes Three Cancer Trial Eligibility Guidances

Jul 30, 20265 min read

FDA

FDA Approves MannKind’s 10-Second Heart-Failure Autoinjector

Jul 27, 20265 min read

Clinical

CHMP Rejects Arimoclomol Again; Zevra Seeks Re-Examination

Jul 27, 20266 min read

FDA

FDA’s Cell Therapy Panel Revisits a Once-Rejected DMD Drug

Jul 26, 20266 min read

Clinical

CHMP Backs the EU’s First Refillable Eye Implant

Jul 26, 20266 min read

FDA

FDA Sets a July 30 Panel on Replimune’s Melanoma Drug

Jul 17, 20265 min read

Guidance

FDA Retires a 1995 Guidance on Topical Steroids

Jul 17, 20265 min read

FDA

FDA Sets a September Hearing on Psychedelic Therapy

Jul 16, 20265 min read

FDA

FDA’s Psychedelics Guidance Is Final, After Three Years

Jul 15, 20265 min read